DecisionHealth, DecisionHealth - 2004 Issue 2 (February)
Urology Coder's Pink Sheet Briefs
Subscribe or sign in to view the full article.
Article Overview
This brief covers coding and reimbursement topics relevant to urology, with emphasis on prostate-related procedures and Medicare policy commentary. It is useful for coders, billers, and practice staff who monitor CPT/HCPCS issues, Federal Register updates, and payment policy changes affecting urologic services and drugs.
Why This Topic Matters
The article flags a potential coding gap for a prostate procedure and places it in the context of Medicare guidance and Part B drug payment policy. Readers tracking urology coding changes can use it to understand the general policy direction and why a new code was being discussed.
Article Sections
-
New code needed for PVP?
Discussion of a prostate-related procedure and the related concern that existing procedure coding may not fully capture the service. The section also references Medicare commentary on whether a separate code may be appropriate.
-
Clarification: The “least costly alternative” concept is not dead – yet.
A policy update on Medicare drug pricing and fee schedule developments affecting prostate cancer therapies and Part B reimbursement methodology. The section summarizes broader regulatory and market-based payment discussion.
-
Correction
A brief published correction unrelated to coding guidance.
What You Will Learn
- The general coding and reimbursement issues discussed for a prostate-related procedure
- How the article frames Medicare and Federal Register policy commentary
- What broader Part B drug pricing topic is being connected to urology billing concerns
- That the piece includes a published correction notice
Who Should Read This
- Urology coders
- Medical billers
- Revenue cycle staff
- Practice managers
- Compliance staff
- Physician office administrators
Codes Discussed
Subscribe or sign in to view the full article.



Quick, Current, Complete - www.findacode.com